SOURCE: Xtalks

Xtalks Webinars

November 24, 2015 07:00 ET

Top News Stories You Might Have Missed From Xtalks

Xtalks Provides Current Articles Daily in the Life Science Industry

TORONTO, ON--(Marketwired - November 24, 2015) - Check out all news stories here: http://xtalks.com/News.ashx

Subscribe to our weekly newsletter: http://register.xtalks.com/newsblogs

Orphan Drug Designation Exploited By Developers -- http://ow.ly/UZ7pf
(Nov 23) Researchers at Johns Hopkins Medicine are urging federal regulators to tighten rules governing the Orphan Drug Act, to prevent exploitation of subsidies and tax breaks by big pharmaceutical companies

Intelligent Biogel Delivers Targeted Immunotherapy Cancer Treatment -- http://ow.ly/UZ7sI
(Nov 23) A so-called 'smart biogel' to deliver cancer therapies directly to the tumor site, is currently in development by a team of researchers at the University of Montreal Hospital Research Centre (CRCHUM), in Canada.

Pfizer and Allergan In Advanced Talks Over Merger -- http://ow.ly/UZ7w6
(Nov 20) It's reported that Pfizer and Allergan are in advanced talks over their proposed megamerger -- and Pfizer could pay as much as $380 per share to acquire the Ireland-based drug developer.

Genetically Modified Salmon Approved By FDA For Consumption In US -- http://ow.ly/UZ7z9
(Nov 20) The US Food and Drug Administration (FDA) has approved the sale of genetically modified salmon for human consumption stating, "food from the fish is safe to eat."

AMA Wants End To Direct-To-Consumer Advertising For Prescription Drugs and Medical Devices -- http://ow.ly/UZ7DW
(Nov 19) The American Medical Associate (AMA) is advocating for a ban on direct-to-consumer (DTC) advertising for prescription pharmaceuticals, as well as medical devices.

Blood Test Results Vary From Drop To Drop -- http://ow.ly/UZ7WM
(Nov 19) According to a new study published in the American Journal of Clinical Pathology, healthcare providers should be wary of drawing conclusions based on test results from a single drop of blood.

FDA Announces Greater Oversight For Laboratory Developed Tests -- http://ow.ly/UZ80O
(Nov 18) Yesterday the US Food and Drug Administration (FDA) issued a report on laboratory developed tests (LDT) -- diagnostic tests that have been designed and manufactured for use in a single laboratory.

FDA Recalls Endoscope Washers Manufactured By Custom Ultrasonics -- http://ow.ly/UZ84s
(Nov 18) FDA Recalls Endoscope Washers Manufactured By Custom Ultrasonics

Gene Therapy For Cystic Fibrosis -- http://ow.ly/UZ88X
(Nov 17) A novel form of gene therapy has been used to successfully treat mice with cystic fibrosis.

California-Based KaloBios Pharmaceuticals Announces Shut Down -- http://ow.ly/UZ8cw
(Nov 17) Representatives from KaloBios announced Friday that they are beginning the process of closing the company's doors and liquidating their assets.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com.
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx.

Contact Information